Skip to main content

Acumen Pharmaceuticals, Inc S-3, filed Oct 26, 2026

Acumen Pharmaceuticals, Inc. (ABOS)

Acumen Pharmaceuticals filed a shelf registration to sell up to $500,000,000 of any combination of common stock, preferred stock, debt securities and warrants, in one or more offerings. The last reported sale price was $1.98 per share on October 23, 2026. AI summary

S-3 2026-10-26
View Original
Added on October 27, 2026